DV
Dividend Vision

CMPX — Compass Therapeutics, Inc.

Compass Therapeutics, Inc. (CMPX)

Its deepest 1-year drawdown was 75.0%.

CMPX is an individual equity stock in the biotechnology sector, not an ETF or diversified fund. As a single-company holding, it carries concentrated company-specific risk rather than the diversification benefits typical of ETFs. The stock does not currently pay dividends, making it unsuitable for income-focused investors seeking regular distributions.

CMPX key facts

Asset type
Stock
Asset class
Equity
Inception date
09/16/1988
Distribution frequency
None
Last close
$2.25
Market cap
$405,197,824
Average volume
1362180.0
Beta
0.818
Payout ratio
0.0
Forward P/E
0.0
EPS
$-0.39